WHO ICTRP trial
Targeted enhanced surveillance to observe vaccine impact against Pneumococcus
ACTRN12614000354684 · Australian New Zealand Clinical Trials Registry (ANZCTR) · Recruiting
Key facts
| Trial ID | ACTRN12614000354684 |
|---|---|
| Public title | Targeted enhanced surveillance to observe vaccine impact against Pneumococcus |
| Scientific title | Evaluation of the effectiveness of the 13-valent pneumococcal conjugate vaccine against pneumococcal pneumonia in children |
| Primary sponsor | University of New South Wales |
| Secondary sponsors | Professor Adam Jaffe |
| Registry | Australian New Zealand Clinical Trials Registry (ANZCTR) |
| Recruitment status | Recruiting |
| Study type | Observational |
| Phase | Not Applicable |
| Countries | Australia |
| Conditions | Pneumonia;Streptococcus pneumoniae;Empyema; Pneumonia Streptococcus pneumoniae Empyema;Infection - Studies of infection and infectious agents;Respiratory - Other respiratory disorders / diseases;Public Health - Other public health |
| Interventions | Pneumonia caused by Streptococcus pneumoniae is a leading cause of childhood morbidity and mortality. While vaccination programs against pneumococcus are highly effective in reducing invasive pneumococcal disease, there are concerns that… |
| Registration date | Feb 4, 2014 |
| Target size | 2200 |
| Secondary IDs | Nil |
| Registry page | anzctr.org.au |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: